Eizen Joshua M 4
4 · AN2 Therapeutics, Inc. · Filed Jan 7, 2025
Insider Transaction Report
Form 4
Eizen Joshua M
See Remarks
Transactions
- Sale
Common Stock
2025-01-03$1.34/sh−9,663$12,958→ 116,672 total
Footnotes (2)
- [F1]Represents shares sold pursuant to the terms of the grant to satisfy tax withholding obligations arising from the vesting of Restricted Stock Units ("RSUs") on January 1, 2025.
- [F2]Includes (a) 31,500 RSUs which vest as follows: 1/4th of the RSUs vest annually over four years from November 4, 2024 (b) 22,500 RSUs which vest as follows: 1/3rd of the RSUs vest annually over three years from January 1, 2025 and (c) 45,000 RSUs which vest as follows: 2/3rd of the RSU vest on January 1, 2026 and 1/3rd of the RSUs vest on July 1, 2026, subject to the Reporting Person's continuous service as of such date.